MGMT and glioblastoma: Although GBM patients with PFS > 12 months also had longer PPS, this could be attributed to a more likely methylated MGMT promotor, e.g. the patient groups with ≤3 months and >12 months PFS had a methylation rate of MGMT of 28% and 46%.